Published in ASAIO J on August 13, 2004
The effects of cell culture parameters on cell release kinetics from thermoresponsive surfaces. J Appl Biomater Biomech (2010) 0.85
Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges. Biomatter (2013) 0.78
Creation of a long-lifespan ciliated epithelial tissue structure using a 3D collagen scaffold. Biomaterials (2010) 0.75
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med (2006) 4.53
Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation (2005) 3.10
Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol (2004) 2.69
Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet (2007) 2.48
Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies. J Am Coll Cardiol (2006) 2.44
Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol (2008) 2.29
Hemolytic anemia after operation for aortic dissection using teflon felt strips. Ann Thorac Surg (2008) 2.00
Patency rate of the internal thoracic artery to the left anterior descending artery bypass is reduced by competitive flow from the concomitant saphenous vein graft in the left coronary artery. Eur J Cardiothorac Surg (2008) 1.83
Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve. Circulation (2003) 1.69
A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest (2007) 1.61
Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model. J Heart Lung Transplant (2005) 1.60
Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett (2007) 1.60
Impact of age at Fontan completion on postoperative hemodynamics and long-term aerobic exercise capacity in patients with dominant left ventricle. Ann Thorac Surg (2009) 1.58
National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation (2004) 1.58
Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res (2005) 1.55
Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol (2007) 1.54
Evolving arch surgery using integrated antegrade selective cerebral perfusion: impact of axillary artery perfusion. J Thorac Cardiovasc Surg (2008) 1.53
Evolving selective cerebral perfusion for aortic arch replacement: high flow rate with moderate hypothermic circulatory arrest. Ann Thorac Surg (2008) 1.53
Angiographic evaluation of flow distribution in sequential and composite arterial grafts for three vessel disease. Eur J Cardiothorac Surg (2011) 1.52
Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model. J Thorac Cardiovasc Surg (2007) 1.52
Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells (2007) 1.51
Japanese guidance for ventricular assist devices/total artificial hearts. Artif Organs (2010) 1.49
Limitations of EuroSCORE for measurement of risk-stratified mortality in aortic arch surgery using selective cerebral perfusion: is advanced age no longer a risk? Ann Thorac Surg (2006) 1.49
Engineering bioartificial tracheal tissue using hybrid fibroblast-mesenchymal stem cell cultures in collagen hydrogels. Interact Cardiovasc Thorac Surg (2010) 1.46
Reasonable and effective volume reduction of a giant left atrium associated with mitral valve disease. Ann Thorac Cardiovasc Surg (2008) 1.45
Preoperative small pulmonary artery did not affect the midterm results of Fontan operation. Eur J Cardiothorac Surg (2007) 1.42
Local delivery of low-dose docetaxel, a novel microtubule polymerizing agent, reduces neointimal hyperplasia in a balloon-injured rabbit iliac artery model. Cardiovasc Res (2002) 1.42
Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun (2008) 1.42
In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J Biomed Mater Res A (2003) 1.42
Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation (2008) 1.40
Modification of bicaval anastomosis for orthotopic cardiac transplantation. Ann Thorac Surg (2004) 1.38
Spinal cord malperfusion caused by using the segmental clamp technique during descending aortic repair for chronic type B aortic dissection. Interact Cardiovasc Thorac Surg (2007) 1.38
Is extracorporeal life support contraindicated in elderly patients? Ann Thorac Surg (2007) 1.38
Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc Natl Acad Sci U S A (2002) 1.34
Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis (2003) 1.30
Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator. J Artif Organs (2007) 1.29
Potential roles of large mafs in cell lineages and developing pancreas. Pancreas (2006) 1.27
Total arch replacement using antegrade selective cerebral perfusion with right axillary artery perfusion. Eur J Cardiothorac Surg (2003) 1.27
Surgical treatment of aortic regurgitation due to Takayasu arteritis: long-term morbidity and mortality. Circulation (2005) 1.25
Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol (2006) 1.22
At least thirty-four days of animal continuous perfusion by a newly developed extracorporeal membrane oxygenation system without systemic anticoagulants. Artif Organs (2002) 1.16
Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells (2008) 1.14
Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease. J Thorac Cardiovasc Surg (2002) 1.14
Ectopic pancreas in the anterior mediastinum. Jpn J Thorac Cardiovasc Surg (2005) 1.13
The use of high-hydrostatic pressure treatment to decellularize blood vessels. Biomaterials (2010) 1.10
Pulsatile control of rotary blood pump and cardiac workload. J Thorac Cardiovasc Surg (2013) 1.08
Successful surgical treatment for aneurysm of splenic artery with anomalous origin. Ann Thorac Cardiovasc Surg (2005) 1.07
Biventricular repair for right atrial isomerism. Ann Thorac Surg (2006) 1.07
Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol (2002) 1.06
Effects of mechanical valve orifice direction on the flow pattern in a ventricular assist device. J Artif Organs (2007) 1.05
Adrenomedullin: angiogenesis and gene therapy. Am J Physiol Regul Integr Comp Physiol (2005) 1.04
Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization. Circulation (2005) 1.03
Ability for basic movement as an early predictor of functioning related to activities of daily living in stroke patients. Neurorehabil Neural Repair (2007) 1.03
Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation. J Thorac Cardiovasc Surg (2005) 1.03
Early clinical outcomes of new pediatric extracorporeal life support system (Endumo (2000) in neonates and infants. J Artif Organs (2013) 1.03
Mesenchymal stem cells for the treatment of heart failure. Int J Hematol (2007) 1.02
Partial anomalous pulmonary venous connection to the superior vena cava. Ann Thorac Surg (2006) 1.01
Development of a novel drive mode to prevent aortic insufficiency during continuous-flow LVAD support by synchronizing rotational speed with heartbeat. J Artif Organs (2013) 1.01
Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status. Int J Oncol (2010) 1.01
G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant (2004) 1.01
What is the ideal off-test trial for continuous-flow ventricular-assist-device explantation? Intracircuit back-flow analysis in a mock circulation model. J Artif Organs (2011) 1.00
Glucose-induced production of hydrogen sulfide may protect the pancreatic beta-cells from apoptotic cell death by high glucose. FEBS Lett (2008) 1.00
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Circulation (2004) 1.00
Trends in the clinical and morphological characteristics of cardiac myxoma: 20-year experience of a single tertiary referral center in Japan. Circ J (2002) 0.99
Japanese multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system. J Artif Organs (2005) 0.98
Improved long-term performance of pulsatile extracorporeal left ventricular assist device. J Cardiol (2010) 0.98
Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience. J Thorac Cardiovasc Surg (2003) 0.98
Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg (2006) 0.98
Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasound and microbubbles. J Control Release (2008) 0.98
Is emergency total arch replacement with a modified elephant trunk technique justified for acute type A aortic dissection? Ann Thorac Surg (2007) 0.97
Alteration of LV end-diastolic volume by controlling the power of the continuous-flow LVAD, so it is synchronized with cardiac beat: development of a native heart load control system (NHLCS). J Artif Organs (2011) 0.97
In-body tissue-engineered aortic valve (Biovalve type VII) architecture based on 3D printer molding. J Biomed Mater Res B Appl Biomater (2014) 0.96
Competitive flow in arterial composite grafts and effect of graft arrangement in Off-Pump coronary revascularization. Ann Thorac Surg (2004) 0.96
Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro. J Thorac Cardiovasc Surg (2003) 0.96
Occlusion of experimental aneurysms with heparin-loaded, microporous stent grafts. Neurosurgery (2003) 0.95
Lamr1 functional retroposon causes right ventricular dysplasia in mice. Nat Genet (2004) 0.95
Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg (2006) 0.95
Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy. Clin Exp Nephrol (2012) 0.95
Development of a completely autologous valved conduit with the sinus of Valsalva using in-body tissue architecture technology: a pilot study in pulmonary valve replacement in a beagle model. Circulation (2010) 0.95
Development of a compact wearable pneumatic drive unit for a ventricular assist device. J Artif Organs (2008) 0.94
Electrocardiogram-synchronized rotational speed change mode in rotary pumps could improve pulsatility. Artif Organs (2011) 0.94